Tag: technology

5 Steps to Unlock Maximum Value from Cloud | Webinar

On-Demand Webinar

5 Steps to Unlock Maximum Value from Cloud

In the last couple of years, we have witnessed the frantic adoption of cloud by enterprises trying to keep up with innovation. During that time, the definition of cloud value was never standardized across different stakeholder groups, and today many enterprises believe they are not realizing the expected value from cloud. This phenomenon has been exacerbated by the current macroeconomic environment, which has added further pressure on enterprises to justify all investments and maximize value.

In this webinar, our experts will explore the unique opportunity for enterprises to align the definition of cloud value and execute their cloud value realization strategies while facing a constrained macroeconomic environment.

Our speakers will discuss:

  • How can you define value from cloud, and what are the key elements beyond cost?
  • What does value realization mean for different stakeholder groups?
  • How can enterprises align on one consistent definition of value?
  • What is the role of different market participants in helping enterprises realize value?
  • How relevant is cost optimization as a value lever in the current recessionary environment?
  • What are the pragmatic steps enterprises can take to maximize value realization?

Who should attend?

  • CIOs and CTOs
  • IT/BPO strategy heads
  • IT/BPO department heads
  • Heads of outsourcing
  • Procurement managers
  • Global sourcing managers
  • Vendor managers
  • Hyperscaler BU heads
  • Cloud and infrastructure heads
  • Solution leads
  • Cloud architects
Zachariah Chirayil
Practice Director
Ranjan Mukesh
Vice President
Singh Abhishek B
Partner

Decentralized Clinical Trials: What You Need to Know to Unlock Value | Webinar

On-Demand Webinar

Decentralized Clinical Trials: What You Need to Know to Unlock Value

Decentralized clinical trials (DCTs) were a boon during the pandemic. Pharmaceutical enterprises capitalized on the opportunity to conduct remote and virtual trials during a time when isolation was critical. However, in 2023, pharmaceutical enterprises are turning their focus to address new challenges such as scale, data security, and site engagement.

In this webinar, we’ll present insights on the trends pharmaceutical enterprises should expect this year, along with data from our 2023 DCT Platforms PEAK Matrix® assessment to shed light on both the demand and supply side of this market.

Our speakers will discuss:

  • How is the DCT technology market evolving and what does adoption look like across therapy areas and geographies?
  • What sourcing criteria should pharmaceutical enterprises consider for evaluating their DCT needs?
  • What are the supply landscape characteristics and their value propositions?

Who should attend?

  • CEOs, CMOs, CDOs, CTOs
  • Heads of Product Marketing
  • Chief Strategy Officers
  • Chief Commercial Officers
  • Chief Innovation Officers
  • Chief Scientific Officers
  • Heads of Strategy
  • Heads of Analyst Relations
  • Heads of Product Development
  • Heads of Innovation
  • Sourcing Heads
Satija Chunky
Vice President
Shah Nisarg
Practice Director

Generative AI and ChatGPT: Separating Fact from Fiction | LinkedIn Live

LINKEDIN LIVE

Generative AI and ChatGPT: Separating Fact from Fiction

View the event on LinkedIn, which was delivered live on Thursday, April 13, 2023.

If you haven’t experimented with ChatGPT yet, you have at least been following the recent buzz⚡.

💻ChatGPT is one recent example of Generative AI that companies are jumping into. However, while the technology itself has immense potential, much of the recent adoption 👥 has been driven by hype .

What exactly is Generative AI? It is an evolved form of Artificial Intelligence (AI) technology that generates new content in the form of text, images, videos, audio, codes, and more – consensus is that it will influence enterprises and providers significantly.

📢 In this LinkedIn Live, we will provide buyers and providers insights into the latest developments and opportunities, as well as the challenges and possible misconceptions in this dynamic market. The speakers will also discuss how organizations can benefit from Generative AI and what factors to consider while using and investing in it.

What questions does the event address?

✅ What are the strengths and limitations of Generative AI (and ChatGPT) in its current form?
✅ What are some high-value applications and use cases?
✅ What do enterprises and service providers need to keep in mind while adopting Generative AI?
✅ What are the major challenges and best practices to assist adoption?

Meet The Presenters

Andrew Burgess Headshot square
AI Strategist and Ethicist
Founder & CEO, Greenhouse Intelligence
Rickard David
Everest Group
Vijayan Anil
Everest Group

How can we engage?

Please let us know how we can help you on your journey.

Contact Us

"*" indicates required fields

Please review our Privacy Notice and check the box below to consent to the use of Personal Data that you provide.
This field is for validation purposes and should be left unchanged.